Takeover drama between Pfizer and AstraZeneca reached PM’s door
The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In a letter to Cameron,...
James C. Smith elected to Pfizer’s Board of Directors
Pfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the...
Par Pharmaceutical Statement on Brevital® Sodium
Par Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use of Brevital® Sodium (methohexital...
US nets biggest penalties for fraud from pharma
The US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money recovered as penalties in...
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards Provepharm, a French company specialized...
Immune Design starts dosing patients in Phase I study of LV305 immuno-oncology agent
US-based Immune Design has started dosing patients in a Phase I clinical study of LV305, an immuno-oncology investigational agent from its DCVex lentiviral vector...
Biotech Stocks Technical Report — Research on Exact Sciences, Anacor Pharma, Cubist Pharma, and Agenus
On Friday, June 06, 2014, the NASDAQ Composite ended at 4,321.40, up 0.59%, the Dow Jones Industrial Average finished the day 0.52% higher at...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...